| Name | Title | Contact Details |
|---|
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
SMSI is a small business providing management and technical/engineering services to the DOE/NNSA, national laboratories, and industrial clients. Our work with nuclear facility operations and safety has set the standard for excellence. We are the resource for highly technical engineering and nuclear safety basis development, review, and implementation at the national laboratories. SMSI has a demonstrated record of success providing superior people developing and implementing innovative solutions, delivering projects on time and within budget. We build productive relationships by being highly responsive to our customers. Operations began in 2000 with headquarters in Albuquerque, NM, and currently operating offices in Los Alamos, NM and Oak Ridge, TN.
Polestar Solutions & Services is a global AI and analytics company focused on enterprise transformation through data-driven solutions. Founded by experienced technocrats, the company operates in the U.S. and India, with offices in cities like Dallas, Noida, and Mumbai. With over 600 employees, Polestar is projected to grow by 60% globally in the coming year. The company specializes in AI-powered analytics, serving industries such as consumer packaged goods, retail, manufacturing, and pharmaceuticals. Polestar offers a range of services, including generative AI, data engineering, and advanced analytics platforms. It develops tailored solutions for revenue growth management, supply chain optimization, and customer analytics. Polestar is recognized as a Great Place to Work and has received multiple awards for its growth and excellence in AI and analytics services. Its mission is to empower businesses through intelligent, data-driven transformation.
The Minnesota Twins are a professional baseball team based in Minneapolis, Minnesota. They play in the Central Division of Major League Baseballs American League. Winners of the 1987 and 1991 World Series. Stay up to date on everything about the Twins at www.twinsbaseball.com